An Investigation of the Protective Effects of the Hydroalcoholic Extract of Persian Yellow Rose (Rosa foetida Herrm.) on Rats with Parkinson's Disease Induced by 6-Hydroxydopamine
AbstractBackground and Aim: This study was carried out to investigate the protective impacts of Rosa foetida extract on Parkinson's disease. Materials and Methods: Seventy rats were divided into 7 groups of 10, including a sham group, the Parkinsonian group (received 6OHDA), pretreatment and post-treatment groups with Persian yellow rose extract (150 mg/kg and 300 mg/kg), and the positive control (L-DOPA). Animal behavior was evaluated using behavioral tests, including muscle stiffness test, rotarod, and elevated body swing test (EBST). The data were analyzed using SPSS statistical software. Results: The frequency of turning to the right in the EBST test, the muscle stiffness score, and the right as well as left-hand scores in the muscle stiffness test were significantly higher in the Parkinsonian group than in the sham group (P<0.05). The frequency of turning to the right in the post-treatment group with Persian yellow rose extract in doses 150 and 300 mg/kg and in pre-treatment with Persian yellow rose extract in dose 300 was significantly lower than that of the Parkinsonian group (P<0.05). The score of the left and right hand in the pre-treatment group of Persian yellow rose extract at a dose of 300 significantly decreased compared with the Parkinsonian group (P<0.05). The time to maintain balance in the rotarod test was significantly reduced in the Parkinsonian group compared with the sham, and post-treatment as well as pre-treatment groups with different doses of Persian yellow rose extract (P<0.05). Conclusion: According to the results of this study, it can be said that the Persian yellow rose extract protects nerve cells against oxidative damage caused by 6-hydroxydopamine and improves motor symptoms and balance disorders caused by Parkinson's disease.
Vazifehkhah S, Karimzadeh F. Parkinson Disease: from Pathophysiology to the Animal Models. Neurosci J Shefa Khatam. 2016;4(3):91-102.
Simon DK, Tanner CM, Brundin P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med. 2020;36(1):1-12.
Balestrino R, Schapira AH. Parkinson disease. Europ J Neurol. 2020;27(1):27-42.
Melissa, Armstrong , Michael S Okun , Diagnosis and Treatment of Parkinson Disease: A Review JAMA. 2020;323(6):548-560
Srivastav S, Fatima M, Mondal AC. Important medicinal herbs in Parkinson’s disease pharmacotherapy. Biomed Pharmacother. 2017;92(4):856-63.
Asgarpanah J, Ziarati P, Safialdinardebily M. The volatile oil composition of Rosa foetida Herrm. flowers growing wild in Kurdistan province (Iran). J Essential Oil Bear Plant. 2014;17(1):169-72.
Rezghi M, Hosseini DSR, Asgarpanah J. Rosa foetida flowers as a future natural antibacterial agent against the main cause of skin burn wound infections, Pseudomonas aeroginosa. J Herbal Drug. 2015;5(3):209-13.
-Noruzi Z, Moslehi M, Salehi M. Antioxidant activity and phenolic compounds of aqueous and ethanolic extracts of Iranian yellow Nastaran (Rosa foetida Herrm.) and evaluation of antimicrobial properties on Salmonella enterica, Bacillus cereus and Staphylococcus aureus. Iranian J Med Arom Plant. 2020;3(4):55-66.
Nooralizadeh Z, Khangholi S, Khademi O. Antioxidant activity, total polyphenol and ascorbic acid contents of Persian yellow rose (Rosa foetida Herrm.) and dog-rose (Rosa canina L.) collected from West Azarbaijan province-Iran. TMU Uni Med Sci J. 2018;4(12):77-83.
Rose B. Creed, B.S, Matthew S. Goldberg. New Developments in Genetic Rat Models of Parkinson’s Disease. Mov Disord. 2018 May; 33(5): 717–729.
Barnes J, Anderson L, Phillipson J. Herbal medicinesa guide for healthcare professionals. London: Pharmaceutical Press; 2002.
Ilaria R, Davide C, Brigida R, Giuseppe G, Eugenio Sci, Marcello A. Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA HemiParkinsonian Rats. Int. J. Mol. Sci. 2020, 21(8), 2874.
Shabani M, Larizadeh M, Parsania S, Hajali V, Shojaei A. Evaluation of destructive effects of exposure to cisplatin during developmental stage: no profound evidence for sex differences in impaired motor and memory performance. Int J Neurosci. 2012;122(8):439-48.
Aldarmaa J, Liu Z, Long J, Mo X, Ma J, Liu J. Anti-convulsant effect and mechanism of Astragalus mongholicus extract in vitro and in vivo: protection against oxidative damage and mitochondrial dysfunction. Neurochemical research. 2010;35(1):33.
Nasri S, Niknami Z, Ziai S, Roghani M, Kamalinejad M. An investigation into the effect of Morus nigra l. Leaf extract on parkinson's disease symptoms and oxidative stress markers in male rats. J Pharm Res. 2012;1(2):71-9.
Haghdoost-Yazdi H, Sehatbakhsh S, Sophiabadi M, Dargahi T, Yaghubidust M, Piri H. Effect of potassium channel blocker Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson's disease in rats. J Qazvin Uni Med Sci. 2016;20(2):41-8.
Esmaeili MH, Haghdoost Yazdi H, Abbasi E, Farshad N. The effects of sodium hydrosulfide on motor learning in a rat model of parkinson’s disease. J Qazvin Uni Med Sci. 2019;22(6):106-15.
Reyhani RS, Mahmoudi J. Role of adenosine a2a receptors on 6-hydroxydopmaine-induced catalepsy in rats. J Comp Pathobiol. 2015;12(1):30-42.
Setorki M, Mahmoudi R, Zanganehnejad Z. Effect of biarum carduchrum in 6-hydroxydopamine-induced parkinsonism in rats: Using behavioral tests. Snsevar Uni Med Sci J. 2018;1(2):12-23.
Amintaheri N, Tehranipour M, Balanezhad SZ. The Effects of aqueous extracts of Rosa canina L fruit on hippocampus neuronal density in male mouse. Res Med. 2017;41(4):251-7.
Farajpour R, Sadigh-Eteghad S, Ahmadian N, Farzipour M, Mahmoudi J, Majdi A. Chronic administration of Rosa canina hydro-alcoholic extract attenuates depressive-like behavior and recognition memory impairment in diabetic mice: a possible role of oxidative stress. Med Princ Pract. 2017;26(3):245-50.
Liu M, Xu Y, Han X, Liang C, Yin L, Xu L, et al. Potent effects of flavonoid-rich extract from Rosa laevigata Michx fruit against hydrogen peroxide-induced damage in PC12 cells via attenuation of oxidative stress, inflammation and apoptosis. Molecules. 2014;19(8):11816-32.
Esfandiary E, Karimipour M, Mardani M, Ghanadian M, Alaei HA, Mohammadnejad D, et al. Neuroprotective effects of Rosa damascena extract on learning and memory in a rat model of amyloid-β-induced Alzheimer's disease. Adv Biomed Res. 2015;4(13):22-9.
Hatami H, Dehghan G, Alavi F. The Protective Effects of Saffron Extract" Crocus sativus''on Oxidative Stress Reduction in Male Rats with Parkinson’s Disease. Sci J Ilam Univ Med Sci. 2019;27(2):148-58.
- Jiang H, Song N, Jiao Q, Shi L, Du X. Iron pathophysiology in parkinson diseases. Amesterdom: Springer; 2019.
Ikawa M, Okazawa H, Kudo T, Kuriyama M, Fujibayashi Y, Yoneda M. Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu] ATSM PET. Nucl Med Biol. 2011;38(7):945-51.
Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract. 2008;4(11):600-9.
Noruzi Z, Moslehi M, Salehi M. Antioxidant activity and phenolic compounds of aqueous and ethanolic extracts of Iranian yellow Nastaran (Rosa foetida Herrm.) and evaluation of antimicrobial properties on Salmonella enterica, Bacillus cereus and Staphylococcus aureus. Iranian J Med Arom Plant. 2020;3(4):55-66.
Nooralizadeh Z, Khangholi S, Khademi O. Antioxidant activity, total polyphenol and ascorbic acid contents of Persian yellow rose (Rosa foetida Herrm.) and dog-rose (Rosa canina L.) collected from West Azarbaijan province-Iran. TMU Uni Med Sci J. 2018;4(12):77-83
Serteser A, Kargioğlu M, Gök V, Bağci Y, Özcan MM, Arslan D. Determination of antioxidant effects of some plant species wild growing in Turkey. Int J Food Sci Nutr. 2008;59(7-8):643-51.
Stocchi F, Antonini A, Berg D, Bergmans B, Jost W, Katzenschlager R, ET AL."Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus." npj Parkinson's Disease. 2022;8(1): 1-9.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.